Huojun Zhang
Papers
1
Total Citations
9
H-Index
1
About
Dr. Huojun Zhang is a leading clinical researcher in radiation oncology, with a focused expertise in stereotactic body radiation therapy (SBRT) for hepatocellular carcinoma (HCC). His most cited work, a 2017 multi-institutional study, provides a critical safety analysis of robotic SBRT for HCC patients with Child–Turcotte–Pugh Class A liver function. By examining a cohort of 74 patients, Dr. Zhang identified key factors influencing treatment safety, establishing essential guidelines for patient selection and risk management in this high-stakes application. This foundational research, which has garnered 9 citations, directly informs clinical protocols to minimize toxicity while maximizing therapeutic efficacy. Dr. Zhang’s contributions are pivotal in advancing the precision and safety of non-invasive liver cancer treatments, bridging the gap between technological capability and patient-centered outcomes. His work continues to shape best practices in radiation oncology, offering a safer path forward for HCC patients who are often too frail for surgery.
Research Focus
Key Achievements
Top Papers
- 1